|
Market Closed -
OTC Markets
23:59:25 09/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0250 USD | -3.85% |
|
0.00% | -3.85% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Stock exchange
OTC Markets
ADAPY 0.0250 $
-3.85%
5.57K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ADAPY | 0.0250USD | -3.85% | 5.57K $ |
Quotes 5-day view: Adaptimmune Therapeutics plc
Delayed Quote OTC Markets
| 02/09/2026 | 03/09/2026 | 04/09/2026 | 08/09/2026 | 09/09/2026 | |
|---|---|---|---|---|---|
| Last | $0.0250 | $0.0260 | $0.0268 | $0.0260 | $0.0250 |
| Volume | 62,826 | 82,887 | 92,660 | 68,147 | 222,681 |
| Change | -7.41% | +4.00% | +3.08% | -2.99% | -3.85% |
| Opening | $0.0205 | $0.0202 | $0.0220 | $0.0210 | $0.0260 |
| High | $0.0270 | $0.0270 | $0.0268 | $0.0268 | $0.0260 |
| Low | $0.0205 | $0.005000 | $0.0210 | $0.0200 | $0.0210 |
Performance
| 1 day | -3.85% | ||
| Current month | +11.11% | ||
| 1 month | -16.67% | ||
| 3 months | -24.01% | ||
| 6 months | +150.00% | ||
| Current year | -3.85% | ||
| 1 year | -49.19% | ||
| 3 years | -96.60% | ||
| 5 years | -99.60% | ||
| 10 years | -99.66% |
Volumes
marketsDaily volume
222,681
Estimated daily volume
222,681
Avg. Volume 20 sessions
157,299
Daily volume ratio
1.42
Avg. Volume 20 sessions USD
3,932.48
Record volume 1
825,386,452
Record volume 2
556,930,770
Record volume 3
516,546,145
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
6,626,289
Net sales (USD)
5,924,000
Number of employees
272
Sales / Employee (USD)
21,779
Free-Float
14.03 %
Free-Float capitalization (USD)
5,576,103
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.0258
Moving average 20 days
0.0269
Moving average 50 days
0.0307
Moving average 100 days
0.025
Price spread / (MMA5)
+3.20%
Price spread / (MMA20)
+7.60%
Price spread / (MMA50)
+22.80%
Price spread / (MMA100)
0.00%
STIM
RSI 9 days
47.14
RSI 14 days
46.83
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.85% | 0.00% | -49.19% | -96.60% | 6.63M | |
| -0.33% | -5.21% | +45.12% | -2.77% | 80.65B | |
| -1.00% | -3.42% | -19.64% | -36.89% | 59.12B | |
| -3.36% | -10.08% | +454.19% | +25.98% | 54.14B | |
| +0.83% | -3.26% | -9.28% | +30.44% | 50.1B | |
| -1.17% | -8.07% | -2.64% | +146.18% | 45.33B | |
| -0.83% | -5.36% | +46.75% | -18.63% | 31.14B | |
| +1.29% | -2.19% | +47.21% | +96.95% | 25.54B | |
| -3.92% | -8.04% | -5.27% | +146.34% | 21.8B | |
| -0.27% | -3.74% | +64.37% | +99.64% | 16.06B | |
| Average | -0.69% | -3.41% | +57.16% | +39.06% | 38.39B | |
| Weighted average by Cap. | -0.16% | -3.85% | +78.31% | +36.05% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
5eac3e4182884.7NIupsQosQ77APBP1rZc2tCSV0_ZZw5IHcExg5m75-A.oIVY5LEYxmG0NLkKkoImlaf-LzWOX1gsa5d3zdPXrai-lGb8kx_4TJNNqQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 23:59:25 | 0.0250 | 1,000 | 222,110 |
| 23:48:39 | 0.0211 | 140 | 221,110 |
| 23:42:12 | 0.0240 | 1,000 | 220,970 |
| 22:31:35 | 0.0211 | 1,100 | 219,970 |
| 22:31:35 | 0.0220 | 400 | 218,870 |
| 22:27:16 | 0.0250 | 1,500 | 218,470 |
| 21:52:01 | 0.0211 | 2,222 | 216,970 |
| 21:50:55 | 0.0250 | 1,000 | 214,748 |
| 21:42:53 | 0.0210 | 257 | 213,748 |
| 21:39:09 | 0.0220 | 700 | 213,491 |
Price Extremes
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0 | | 0.03 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.28 |
| 3 years | 0 | | 2.05 |
| 5 years | 0 | | 6.84 |
| 10 years | 0 | | 14.62 |
Monthly variations
Annual variations
| 2026 | -3.85% | ||
| 2025 | -95.17% | ||
| 2024 | -32.07% | ||
| 2023 | -45.68% | ||
| 2022 | -61.07% | ||
| 2021 | -30.43% | ||
| 2020 | +349.17% | ||
| 2019 | -79.13% | ||
| 2018 | -13.92% | ||
| 2017 | +64.94% | ||
| 2016 | -66.42% | ||
| 2015 | -30.01% |
- Stock Market
- Stocks
- ADAPY Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
